Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

105.83
Delayed Data
As of 3:59pm ET
 -1.57 / -1.46%
Today’s Change
93.05
Today|||52-Week Range
128.39
-11.63%
Year-to-Date
Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?
11:04am / MotleyFool.com - Paid Partner Content
Allergan's Vitae buy could spark more interest in Kadmon
Sep 23 / TheStreet.com - Paid Partner Content
The 3 Best-Run Companies in the Healthcare Sector
Sep 27 / MotleyFool.com - Paid Partner Content
The Most Exciting Drug in Celgene's Pipeline
Sep 21 / MotleyFool.com - Paid Partner Content
Amgen Multiple Myeloma Drug Kyprolis Fails to Help Newly Diagnosed Patients
Sep 27 / TheStreet.com - Paid Partner Content
Celgene Presents Efficacy & Safety Phase II Ozanimod Data
Sep 20 / Zacks.com - Paid Partner Content
Biotech ETFs May Be a Prescription for Investment Success, Especially If Trump Become...
Sep 26 / TheStreet.com - Paid Partner Content
3 Top Stocks on Sale This Fall
Sep 19 / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Sep 26 / MotleyFool.com - Paid Partner Content
5 Reasons Celgene Is a Buy
Sep 15 / MotleyFool.com - Paid Partner Content